Clearing Up Confusion Around “Bispecific Antibodies”
Last Updated: May 16, 2025
A focus on clarifying terminology and highlighting the differences between observation periods and supportive care.
Find Similar Resources:
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Up Close with Linvoseltamab
Last Updated: 10/10/2025
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 10/10/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 10/10/2025
Example SOPs and Documents: Bispecific T-Cell Engager Ordering and REMS Compliance
Last Updated: 10/10/2025
PQI in Action
Treatment Discussion Guides
Patient Education Sheet
Patient Education Sheet
PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Last Updated: 10/10/2025
Nirogacestat (Ogsiveo): Treatment Discussion Guide
Last Updated: 10/10/2025
Vorasidenib
Last Updated: 10/10/2025
Encorafenib and Binimetinib
Last Updated: 10/10/2025